We've found
15,024
archived clinical trials in
Infectious Disease
We've found
15,024
archived clinical trials in
Infectious Disease
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol Post Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol POST-THERAPY
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects
Updated: 12/31/1969
Helicobacter Pylori Sample Collection Protocol PRE-THERAPY
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years
Updated: 12/31/1969
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children 2 to 9 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials